Gidon Akler, MD talks about collecting samples and sequence genomes from COVID-19 patients. They hope this will help identify protective and risk-bearing genetic factors, there would help in diagnostic and treatment methods.
Below is a summary:
The Israel Ministry of Health and the Israel Innovation Authority, along with Sourasky (Ichilov) Medical Center and Rambam Health Care Campus in addition to a startup venture called Geneyx have formed a public-private consortium that will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the aim of identifying new diagnostic and treatment methods. The startup offers next-generation sequencing data analysis, interpretation, reporting and storage products, and services.